Critical Care Pharmacy Services (ACCP)

2002 ◽  
pp. 240-245
2006 ◽  
Vol 40 (4) ◽  
pp. 612-618 ◽  
Author(s):  
Robert MacLaren ◽  
John W Devlin ◽  
Steven J Martin ◽  
Joseph F Dasta ◽  
Maria I Rudis ◽  
...  

2000 ◽  
Vol 28 (11) ◽  
pp. 3746-3750 ◽  
Author(s):  
Maria I. Rudis ◽  
Katherine M. Brandl

2020 ◽  
Vol 48 (9) ◽  
pp. 1375-1382
Author(s):  
Ishaq Lat ◽  
Christopher Paciullo ◽  
Mitchell J. Daley ◽  
Robert MacLaren ◽  
Scott Bolesta ◽  
...  

2021 ◽  
Vol 3 (1) ◽  
pp. e0323
Author(s):  
Robert MacLaren ◽  
Russel J. Roberts ◽  
Amy L. Dzierba ◽  
Mitchell Buckley ◽  
Ishaq Lat ◽  
...  

2016 ◽  
Vol 51 (10) ◽  
pp. 856-862 ◽  
Author(s):  
Brian L. Erstad ◽  
Henry J. Mann ◽  
Robert J. Weber

2020 ◽  
Vol 77 (19) ◽  
pp. 1619-1624
Author(s):  
Ishaq Lat ◽  
Christopher Paciullo ◽  
Mitchell J Daley ◽  
Robert MacLaren ◽  
Scott Bolesta ◽  
...  

Abstract Objectives Provide a multiorganizational statement to update the statement from a paper in 2000 about critical care pharmacy practice and make recommendations for future practice. Design The Society of Critical Care Medicine, American College of Clinical Pharmacy Critical Care Practice and Research Network, and the American Society of Health-System Pharmacists convened a joint task force of 15 pharmacists representing a broad cross-section of critical care pharmacy practice and pharmacy administration, inclusive of geography, critical care practice setting, and roles. The Task Force chairs reviewed and organized primary literature, outlined topic domains, and prepared the methodology for group review and consensus. A modified Delphi method was used until consensus (>66% agreement) was reached for each practice recommendation. Previous position statement recommendations were reviewed and voted to either retain, revise, or retire. Recommendations were categorized by level of ICU service to be applicable by setting, and grouped into five domains: patient care, quality improvement, research and scholarship, training and education, and professional development. Main Results There are 82 recommendation statements: forty-four original recommendations and 38 new recommendation statements. Thirty-four recommendations were made for patient care, primarily relating to critical care pharmacist duties and pharmacy services. In the quality improvement domain, 21 recommendations address the role of the critical care pharmacist in patient and medication safety, clinical quality programs, and analytics. Nine recommendations were made in the domain of research and scholarship. Ten recommendations are in the domain of training and education and eight recommendations regarding professional development. Conclusions The statements recommended by this taskforce delineate the activities of a critical care pharmacist and the scope of pharmacy services within the ICU. Effort should be made from all stakeholders to implement the recommendations provided, with continuous effort toward improving the delivery of care for critically ill patients.


Author(s):  
Society of Critical Care Medicine ◽  
American College of Clinical Pharmacy

2019 ◽  
Vol 10 (1) ◽  
pp. 8
Author(s):  
AK Mohiuddin

The beginnings of caring for critically ill patients date back to Florence Nightingale’s work during the Crimean War in 1854, but the subspecialty of critical care medicine is relatively young. The first US multidisciplinary intensive care unit (ICU) was established in 1958, and the American Board of Medical Subspecialties first recognized the subspecialty of critical care medicine in 1986. Critical care pharmacy services began around the 1970s, growing in the intervening 40 years to become one of the largest practice areas for clinical pharmacists, with its own section in the SCCM, the largest international professional organization in the field. During the next decade, pharmacy services expanded to various ICU settings (both adult and pediatric), the operating room, and the emergency department.  In these settings, pharmacists established clinical practices consisting of therapeutic drug monitoring, nutrition support, and participation in patient care rounds. Pharmacists also developed efficient and safe drug delivery systems with the evolution of critical care pharmacy satellites and other innovative programs. In the 1980s, critical care pharmacists designed specialized training programs and increased participation in critical care organizations.    The number of critical care residencies and fellowships doubled between the early 1980s and the late 1990s.  Standards for critical care residency were developed, and directories of residencies and fellowships were published. In 1989, the Clinical Pharmacy and Pharmacology Section was formed within the Society of Critical Care Medicine, the largest international, multidisciplinary, multispecialty critical care organization. This recognition acknowledged that pharmacists are necessary and valuable members of the physician-led multidisciplinary team. The Society of Critical Care Medicine Guidelines for Critical Care Services and Personnel deem that pharmacists are essential for the delivery of quality care to critically ill patients.    These guidelines recommend that a pharmacist monitor drug regimen for dosing, adverse reactions, drug-drug interactions, and cost optimization for all hospitals providing critical care services. The guidelines also advocate that a specialized, decentralized pharmacist provide expertise in nutrition support, cardiorespiratory resuscitation, and clinical research in academic medical centers providing comprehensive critical care.   Article Type: Commentary


Sign in / Sign up

Export Citation Format

Share Document